【24h】

Analysis of Error Detection in EPID-Based IMRT Pre-Treatment QA

机译:基于EPID的IMRT预处理QA中的错误检测分析

获取原文

摘要

A common approach to IMRT pre-treatment quality assurance is to capture images of IMRT fields with no patient or phantom in the beam, and compare these to images predicted by the treatment planning system. This is done prior to treatment in order to detect and correct file transfer and beam delivery errors that would affect the quality of treatment. In many institutions, the distance between measured and predicted images is quantified using gamma indices with 3%/3mm criteria. This work: (i) examines repeated electronic portal imaging device (EPID) images of an IMRT field; (ii) evaluates output variations, alignment errors and measurement 'noise'; and (iii) uses this data with receiver operating curve (ROC) analysis to determine the size of IMRT delivery errors that can be reliably detected. The gamma index with 3%/3mm acceptance criteria is shown to be sub-optimal; dose differences must be >5% in a 24mmx24mm area to be detected 95% of the time, while a pixel intensity difference (PID) test reliably detects >2% dose deviations in the same area. Excluding high gradient regions has little effect on the detection ability of gamma, but allows a PID test to detect 2% dose deviations in 5mmx5min areas.
机译:进行IMRT预处理质量保证的常用方法是捕获光束中没有患者或体模的IMRT场图像,并将其与治疗计划系统预测的图像进行比较。这是在治疗之前完成的,目的是检测并纠正可能影响治疗质量的文件传输和光束传输错误。在许多机构中,使用灰度系数为3%/ 3mm的伽玛指数对测量图像和预测图像之间的距离进行量化。这项工作:(i)检查IMRT场的重复电子门成像设备(EPID)图像; (ii)评估输出变化,对准误差和测量“噪声”; (iii)将此数据与接收器工作曲线(ROC)分析一起使用,以确定可以可靠地检测到的IMRT传递错误的大小。接受标准为3%/ 3mm的伽玛指数显示为次优;在24mmx24mm的区域中,剂量差异必须大于5%,才能在95%的时间内被检测到,而像素强度差异(PID)测试可在同一区域中可靠地检测到大于2%的剂量偏差。排除高梯度区域对γ的检测能力影响很小,但是允许PID测试在5mmx5min的区域中检测到2%的剂量偏差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号